John Stanford

John Stanford is the executive director of Incubate, a Washington-based coalition of life sciences venture capitalists, and Incubate Coalition Japan, an organization focused on strengthening Japan’s life sciences ecosystem.

If the U.S. can help Japan reform its drug pricing controls, both countries stand to benefit.
The current state of political affairs in the U.S. does not bode well for the direction of that turn. The country is at real risk of losing its long-held lead in biotech innovation.
Drug pricing, budget cuts, tariffs and other shifts under the Trump administration undermine the biopharma and healthcare ecosystem.
Many promising small molecules have lost significant investment appeal as a result of lopsided incentives favoring biologics in 2022’s Inflation Reduction Act.